ORBIMED ADVISORS LLC

Position in MYGN — Myriad Genetics Inc

CIK 1055951 New York, NY

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$562,500,000

New position

Shares Held

125,000,000

first reported quarter

Ownership

132.3%

of shares outstanding

% of Portfolio

11.42%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $728,348,629 across 5 Diagnostics & Research names. MYGN ranks #1 (77.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MYGN	Myriad Genetics Inc This page	125,000,000	$562,500,000
2	NTRA	Natera, Inc.	262,000	$52,397,380
3	DHR	Danaher Corp /De/	265,800	$50,395,680
4	GH	Guardant Health, Inc.	435,200	$40,199,424
5	TMO	Thermo Fisher Scientific Inc.	46,500	$22,856,145

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$562,500,000	125,000,000	—	Principal	Sole	2026-05-15
No filing history on record for this holder in this stock.